166 related articles for article (PubMed ID: 19879945)
1. Simple and scalable method for peptide inhalable powder production.
Schoubben A; Blasi P; Giovagnoli S; Ricci M; Rossi C
Eur J Pharm Sci; 2010 Jan; 39(1-3):53-8. PubMed ID: 19879945
[TBL] [Abstract][Full Text] [Related]
2. Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery.
Giovagnoli S; Blasi P; Schoubben A; Rossi C; Ricci M
Int J Pharm; 2007 Mar; 333(1-2):103-11. PubMed ID: 17079101
[TBL] [Abstract][Full Text] [Related]
3. Capreomycin oleate microparticles for intramuscular administration: Preparation, in vitro release and preliminary in vivo evaluation.
Cambronero-Rojas A; Torres-Vergara P; Godoy R; von Plessing C; Sepúlveda J; Gómez-Gaete C
J Control Release; 2015 Jul; 209():229-37. PubMed ID: 25956458
[TBL] [Abstract][Full Text] [Related]
4. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
5. Capreomycin inhalable powders prepared with an innovative spray-drying technique.
Schoubben A; Giovagnoli S; Tiralti MC; Blasi P; Ricci M
Int J Pharm; 2014 Jul; 469(1):132-9. PubMed ID: 24747443
[TBL] [Abstract][Full Text] [Related]
6. Thermal behavior and stability of biodegradable spray-dried microparticles containing triamcinolone.
da Silva AA; de Matos JR; Formariz TP; Rossanezi G; Scarpa MV; do Egito ES; de Oliveira AG
Int J Pharm; 2009 Feb; 368(1-2):45-55. PubMed ID: 18992313
[TBL] [Abstract][Full Text] [Related]
7. Effect of carrier morphology and surface characteristics on the development of respirable PLGA microcapsules for sustained-release pulmonary delivery of insulin.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Int J Pharm; 2010 Apr; 389(1-2):74-85. PubMed ID: 20085803
[TBL] [Abstract][Full Text] [Related]
8. Powder, capsule and device: An imperative ménage à trois for respirable dry powders.
Schoubben A; Blasi P; Giontella A; Giovagnoli S; Ricci M
Int J Pharm; 2015 Oct; 494(1):40-8. PubMed ID: 26255220
[TBL] [Abstract][Full Text] [Related]
9. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
Ohashi K; Kabasawa T; Ozeki T; Okada H
J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349
[TBL] [Abstract][Full Text] [Related]
10. Preparation and evaluation of poly(lactic-co-glycolic acid) microparticles as a carrier for pulmonary delivery of recombinant human interleukin-2: II. In vitro studies on aerodynamic properties of dry powder inhaler formulations.
Devrim B; Bozkır A; Canefe K
Drug Dev Ind Pharm; 2011 Nov; 37(11):1376-86. PubMed ID: 21548727
[TBL] [Abstract][Full Text] [Related]
11. Capreomycin supergenerics for pulmonary tuberculosis treatment: preparation, in vitro, and in vivo characterization.
Schoubben A; Blasi P; Marenzoni ML; Barberini L; Giovagnoli S; Cirotto C; Ricci M
Eur J Pharm Biopharm; 2013 Apr; 83(3):388-95. PubMed ID: 23220041
[TBL] [Abstract][Full Text] [Related]
12. Preparation and in vivo evaluation of a dry powder for inhalation of capreomycin.
Fiegel J; Garcia-Contreras L; Thomas M; VerBerkmoes J; Elbert K; Hickey A; Edwards D
Pharm Res; 2008 Apr; 25(4):805-11. PubMed ID: 17657592
[TBL] [Abstract][Full Text] [Related]
13. Influence of post-emulsification drying processes on the microencapsulation of human serum albumin.
Lane ME; Brennan FS; Corrigan OI
Int J Pharm; 2006 Jan; 307(1):16-22. PubMed ID: 16274944
[TBL] [Abstract][Full Text] [Related]
14. Powder properties and their influence on dry powder inhaler delivery of an antitubercular drug.
Sethuraman VV; Hickey AJ
AAPS PharmSciTech; 2002; 3(4):E28. PubMed ID: 12916922
[TBL] [Abstract][Full Text] [Related]
15. Spray freeze drying to produce a stable Delta(9)-tetrahydrocannabinol containing inulin-based solid dispersion powder suitable for inhalation.
van Drooge DJ; Hinrichs WL; Dickhoff BH; Elli MN; Visser MR; Zijlstra GS; Frijlink HW
Eur J Pharm Sci; 2005 Oct; 26(2):231-40. PubMed ID: 16084699
[TBL] [Abstract][Full Text] [Related]
16. Preparation of protein loaded poly(D,L-lactide-co-glycolide) microparticles for the antigen delivery to dendritic cells using a static micromixer.
Wischke C; Lorenzen D; Zimmermann J; Borchert HH
Eur J Pharm Biopharm; 2006 Apr; 62(3):247-53. PubMed ID: 16288857
[TBL] [Abstract][Full Text] [Related]
17. Development of highly porous large PLGA microparticles for pulmonary drug delivery.
Yang Y; Bajaj N; Xu P; Ohn K; Tsifansky MD; Yeo Y
Biomaterials; 2009 Apr; 30(10):1947-53. PubMed ID: 19135245
[TBL] [Abstract][Full Text] [Related]
18. Nano and microparticle engineering of water insoluble drugs using a novel spray-drying process.
Schafroth N; Arpagaus C; Jadhav UY; Makne S; Douroumis D
Colloids Surf B Biointerfaces; 2012 Feb; 90():8-15. PubMed ID: 22019455
[TBL] [Abstract][Full Text] [Related]
19. Spray-drying preparation of microparticles containing cationic PLGA nanospheres as gene carriers for avoiding aggregation of nanospheres.
Takashima Y; Saito R; Nakajima A; Oda M; Kimura A; Kanazawa T; Okada H
Int J Pharm; 2007 Oct; 343(1-2):262-9. PubMed ID: 17628365
[TBL] [Abstract][Full Text] [Related]
20. A Spray-Dried Combination of Capreomycin and CPZEN-45 for Inhaled Tuberculosis Therapy.
Pitner RA; Durham PG; Stewart IE; Reed SG; Cassell GH; Hickey AJ; Carter D
J Pharm Sci; 2019 Oct; 108(10):3302-3311. PubMed ID: 31152746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
